Aspirin doesn't help Breast Cancer outcomes

Researchers found no link between taking aspirin and improved breast cancer outcomes, however the drug's effect on breast density may help with earlier diagnosis, according to two new studies presented at a conference on breast cancer.
Several studies have shown aspirin to cut the risk of colorectal, breast and other cancers.
Researchers from the University of Pennsylvania presented the new studies at the San Antonio Breast Cancer Symposium. "Past studies have found that aspirin may hold anti-cancer benefits. However, many of them were preliminary, preclinical, and didn't support a clear mortality benefit. They also didn't look at prior use of aspirin," said Dr. Julia Tchou, an associate professor of surgery at the University of Pennsylvania. "Our data did not support the notion that this century-old pill has protective qualities and down-the-road benefits for breast cancer patients. However, larger patient cohort studies are needed to confirm our results."